Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

HER3 (erbB3) signaling serves an important role in the development and chemoresistance of ovarian cancer, and is activated by chemotherapy. To evaluate the influence of neoadjuvant chemotherapy and other clinical factors on the expression of HER3, as well as to examine its role as a prognostic marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Takaaki, Kojima, Yuki, Yonemori, Kan, Yoshida, Hiroshi, Sugiura, Yukiko, Ohtake, Yohei, Okuma, Hitomi S., Nishikawa, Tadaaki, Tanioka, Maki, Sudo, Kazuki, Shimomura, Akihiko, Noguchi, Emi, Kato, Tomoyasu, Shimoi, Tatsunori, Uno, Masaya, Ishikawa, Mitsuya, Fujiwara, Yasuhiro, Ohe, Yuichiro, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583842/
https://www.ncbi.nlm.nih.gov/pubmed/33123247
http://dx.doi.org/10.3892/ol.2020.12200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583842/
https://www.ncbi.nlm.nih.gov/pubmed/33123247
http://dx.doi.org/10.3892/ol.2020.12200

Ejemplares similares